Dallas Jayson Donald Alexander Insider Trades

Insider Trading History

Track insider trading activity for Dallas Jayson Donald Alexander. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Galecto
Galecto GLTO
Director
Holding Value $15.5k 720 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.32k 720 shares
$3.22
$21.58
Galecto
Galecto GLTO
Director
Holding Value $388k 18,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.82k 18,000 shares
$0.49
$21.58
Galecto
Galecto GLTO
Director
Holding Value $388k 18,000 shares
Last Trade
Jun 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.1k 18,000 shares
$2.84
$21.58
Galecto
Galecto GLTO
Director
Holding Value $388k 18,000 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.6k 18,000 shares
$1.81
$21.58
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Director
Holding Value $0 0 shares
Last Trade
Mar 11, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$720k 7,202 shares
$99.99
$99.99
Galecto
Galecto GLTO
Director
Holding Value $388k 18,000 shares
Last Trade
May 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$88.7k 18,000 shares
$4.93
$21.58
Galecto
Galecto GLTO
Director
Holding Value $388k 18,000 shares
Last Trade
Nov 19, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$448k 27,000 shares
$16.60
$21.58
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $685k 23,830 shares
Last Trade
Jun 01, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.7k 294 shares
$73.73
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $679k 23,604 shares
Last Trade
Apr 19, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77.1k 1,431 shares
$53.87
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $638k 22,173 shares
Last Trade
Mar 01, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.4k 441 shares
$48.43
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $920k 32,000 shares
Last Trade
Mar 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.86M 38,500 shares
$48.43
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $463k 16,107 shares
Last Trade
Aug 03, 2017 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$58.8k 940 shares
$62.59
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $490k 17,047 shares
Last Trade
Jun 01, 2017 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.1k 320 shares
$56.61
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $863k 30,000 shares
Last Trade
Mar 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.06M 34,500 shares
$88.80
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
See Remarks
Holding Value $358k 12,460 shares
Last Trade
Aug 04, 2016 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$60.4k 940 shares
$64.24
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
See Remarks
Holding Value $316k 11,000 shares
Last Trade
Jun 03, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$765k 11,000 shares
$69.53
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
See Remarks
Holding Value $581k 20,200 shares
Last Trade
Jun 01, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.67M 23,600 shares
$70.57
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
See Remarks
Holding Value $2.59M 90,000 shares
Last Trade
Aug 04, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.5M 100,000 shares
$104.81
$28.76

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up